173 related articles for article (PubMed ID: 12191827)
1. Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans.
Gerra G; Zaimovic A; Moi G; Giusti F; Gardini S; Delsignore R; Laviola G; Macchia T; Brambilla F
Behav Brain Res; 2002 Aug; 134(1-2):403-10. PubMed ID: 12191827
[TBL] [Abstract][Full Text] [Related]
2. Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.
Gerra G; Zaimovic A; Ferri M; Zambelli U; Timpano M; Neri E; Marzocchi GF; Delsignore R; Brambilla F
Biol Psychiatry; 2000 Jan; 47(2):127-36. PubMed ID: 10664829
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine ('ecstasy') use history: correlation with dopamine receptor sensitivity.
Gerra G; Bassignana S; Zaimovic A; Moi G; Bussandri M; Caccavari R; Brambilla F; Molina E
Psychiatry Res; 2003 Sep; 120(2):115-24. PubMed ID: 14527643
[TBL] [Abstract][Full Text] [Related]
4. Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine ('Ecstasy') in humans.
Gerra G; Zaimovic A; Giucastro G; Maestri D; Monica C; Sartori R; Caccavari R; Delsignore R
Int Clin Psychopharmacol; 1998 Jan; 13(1):1-9. PubMed ID: 9988361
[TBL] [Abstract][Full Text] [Related]
5. Experimentally induced aggressive behavior in subjects with 3,4-methylenedioxy-methamphetamine ("Ecstasy") use history: psychobiological correlates.
Gerra G; Zaimovic A; Ampollini R; Giusti F; Delsignore R; Raggi MA; Laviola G; Macchia T; Brambilla F
J Subst Abuse; 2001; 13(4):471-91. PubMed ID: 11775077
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine correlates of temperamental traits in humans.
Gerra G; Zaimovic A; Timpano M; Zambelli U; Delsignore R; Brambilla F
Psychoneuroendocrinology; 2000 Jul; 25(5):479-96. PubMed ID: 10818282
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine correlates of depression in abstinent heroin-dependent subjects.
Gerra G; Zaimovic A; Zambelli U; Delsignore R; Baroni MC; Laviola G; Macchia T; Brambilla F
Psychiatry Res; 2000 Nov; 96(3):221-34. PubMed ID: 11084218
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats.
Schenk S; Gittings D; Colussi-Mas J
Br J Pharmacol; 2011 Apr; 162(8):1770-80. PubMed ID: 21198550
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic changes in ventral midbrain dopaminergic neurons resulting from (+/-) -3,4-methylenedioxymethamphetamine (MDMA-"Ecstasy").
Federici M; Sebastianelli L; Natoli S; Bernardi G; Mercuri NB
Biol Psychiatry; 2007 Sep; 62(6):680-6. PubMed ID: 17511969
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine correlates of antisocial personality disorder in abstinent heroin-dependent subjects.
Gerra G; Zaimovic A; Moi G; Bussandri M; Delsignore R; Caccavari R; Brambilla F
Addict Biol; 2003 Mar; 8(1):23-32. PubMed ID: 12745412
[TBL] [Abstract][Full Text] [Related]
11. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
Morgan MJ
Neuropsychopharmacology; 1998 Oct; 19(4):252-64. PubMed ID: 9718589
[TBL] [Abstract][Full Text] [Related]
12. Aggressive responding in abstinent heroin addicts: neuroendocrine and personality correlates.
Gerra G; Zaimovic A; Moi G; Bussandri M; Bubici C; Mossini M; Raggi MA; Brambilla F
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):129-39. PubMed ID: 14687867
[TBL] [Abstract][Full Text] [Related]
13. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Taurah L; Chandler C; Sanders G
Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426
[TBL] [Abstract][Full Text] [Related]
14. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.
Vegting Y; Reneman L; Booij J
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3473-501. PubMed ID: 27568200
[TBL] [Abstract][Full Text] [Related]
15. Experimentally induced aggressiveness in adult children of alcoholics (ACOAs): preliminary behavioral and neuroendocrine findings.
Gerra G; Zaimovic A; Sartori R; Raggi MA; Bocchi C; Zambelli U; Timpano M; Zanichelli V; Delsignore R; Brambilla F
J Stud Alcohol; 1999 Nov; 60(6):776-83. PubMed ID: 10606489
[TBL] [Abstract][Full Text] [Related]
16. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice.
Risbrough VB; Masten VL; Caldwell S; Paulus MP; Low MJ; Geyer MA
Neuropsychopharmacology; 2006 Nov; 31(11):2349-58. PubMed ID: 16855533
[TBL] [Abstract][Full Text] [Related]
17. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
Parrott AC; Lasky J
Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
[TBL] [Abstract][Full Text] [Related]
18. Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence.
Dafters RI; Duffy F; O'Donnell PJ; Bouquet C
Psychopharmacology (Berl); 1999 Jul; 145(1):82-90. PubMed ID: 10445376
[TBL] [Abstract][Full Text] [Related]
19. No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study.
Gamma A; Buck A; Berthold T; Vollenweider FX
J Clin Psychopharmacol; 2001 Feb; 21(1):66-71. PubMed ID: 11199950
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users.
Back-Madruga C; Boone KB; Chang L; Grob CS; Lee A; Nations H; Poland RE
Clin Neuropsychol; 2003 Nov; 17(4):446-59. PubMed ID: 15168910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
